4.7 Review

Matricellular proteins in drug delivery: Therapeutic targets, active agents, and therapeutic localization

期刊

ADVANCED DRUG DELIVERY REVIEWS
卷 97, 期 -, 页码 56-68

出版社

ELSEVIER
DOI: 10.1016/j.addr.2015.12.016

关键词

Extracellular matrix; Matricellular; Cell-matrix interactions; Angiogenesis; Fibrosis

资金

  1. National Institutes of Health [GM072194, HL 107205, T32HL007950-12]

向作者/读者索取更多资源

Extracellular matrix is composed of a complex array of molecules that together provide structural and functional support to cells. These properties are mainly mediated by the activity of collagenous and elastic fibers, proteoglycans, and proteins such as fibronectin and laminin. ECM composition is tissue-specific and could include matricellular proteins whose primary role is to modulate cell-matrix interactions. In adults, matricellular proteins are primarily expressed during injury, inflammation and disease. Particularly, they are closely associated with the progression and prognosis of cardiovascular and fibrotic diseases, and cancer. This review aims to provide an overview of the potential use of matricellular proteins in drug delivery including the generation of therapeutic agents based on the properties and structures of these proteins as well as their utility as biomarkers for specific diseases. (C) 2016 Elsevier B.V. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据